The Technical Analyst
Select Language :
Celsion Corp [CLSN]

Exchange: NASDAQ Capital Market Sector: Healthcare Industry: Biotechnology

Celsion Corp Price, Forecast, Insider, Ratings, Fundamentals & Signals

Current Signal: BUY (auto-tracking)

Celsion Corp is listed at the NASDAQ Exchange

0.00% $2.54

Last updated: 8 aug 2022 - 0:02

TimeZone: America/New_York


FUNDAMENTALS
MarketCap: 18.03 mill
EPS: -3.97
P/E: 0.000
Earnings Date: Aug 10, 2022
SharesOutstanding: 7.10 mill
Avg Daily Volume: 0.0648 mill
RATING 2022-08-05
B
Neutral
RATINGDETAILS
Rating CashFlow: Strong Buy
Return On Equity: Sell
Return On Asset: Sell
DE: Neutral
P/E: Sell
Price To Book: Buy
QUARTER GROWTHS
4/201/212/213/214/211/22
Revenuen/an/an/an/an/an/a
Gr.Profitn/an/an/an/an/a
Ebit
Asset
Debt
DISCOUNTED CASH FLOW VALUE
$6.15
(142.16%) $3.61
Date: 2022-08-08
Expected Trading Range (DAY)

$ 2.36 - 2.72

( +/- 7.20%)
ATR Model: 14 days

Insider Trading

Date Person Action Amount type
2022-07-18 Le Goff Corinne Buy 177 000 Stock Option (Right to Buy)
2022-07-18 Le Goff Corinne Buy 53 000 Common Stock
2022-06-13 Kardaras Constantine John Buy 1 750 Option to Purchase Celsion Common Stock
2022-06-13 Tumminello Timothy J Buy 7 500 Option to Purchase Celsion Common Stock
2022-06-13 Fritz Frederick J. Buy 7 500 Option to Purchase Celsion Common Stock
INSIDER POWER
97.20
Last 100 transactions
Buy: 2 950 200 | Sell: 1 490 000

Forecast: 01:40 - $1.266

Live Trading Signals (every 1 min)

SCORE
-10.00
Sell
Score Algorithm Version: 1.2C
Last version updated: Fri April 15th, 2022
Indicator Signals
RSI 21
SMA
Trend
Trend 2
Trend 3
MACD
Volume Signals
Price $2.54 (0.00% )
Volume 0.203 mill
Avg. Vol. 0.0648 mill
% of Avg. Vol 312.79 %
Signal 1:
Signal 2:

Today

Intraday chart data with high, low, open and close for Celsion Corp

Last 12 Months

Last 12 months chart data with high, low, open and close for Celsion Corp

RSI

Intraday RSI14 chart for Celsion Corp

Last 10 Buy & Sell Signals For CLSN

89 Signals | Accuracy: 14.61% | Accuracy Buy: 18.18% | Accuracy Sell: 11.11%

Avg return buy: -0.86 % | Avg return sell: 1.28 %

$1 invested is now $0.68 or -32.01% since 25-07-22

Date Signal @ Closed %
Aug 5 - 09:56buy$2.49N/AActive
Aug 5 - 09:35sell$2.37$2.49 @ Aug 5 - 09:564.86%
Aug 4 - 12:58buy$2.35$2.37 @ Aug 5 - 09:350.85%
Aug 4 - 12:32sell$2.32$2.35 @ Aug 4 - 12:581.29%
Aug 4 - 11:06buy$2.30$2.32 @ Aug 4 - 12:321.02%
Aug 4 - 10:51sell$2.26$2.30 @ Aug 4 - 11:061.62%
Aug 4 - 10:26buy$2.30$2.26 @ Aug 4 - 10:51-1.74%
Aug 3 - 14:57sell$2.27$2.30 @ Aug 4 - 10:261.32%
Aug 3 - 14:34buy$2.30$2.27 @ Aug 3 - 14:57-1.30%
Aug 3 - 11:53sell$2.32$2.30 @ Aug 3 - 14:34-0.65%
The Live Chart for Celsion Corp
Profile picture for
            Celsion Corp

CLSN

Celsion Corporation, an integrated development clinical stage oncology drug company, focuses on the development and commercialization of directed chemotherapies, DNA-mediated immunotherapy, and RNA-based therapies for the treatment of cancer. Its lead product candidate is ThermoDox, a liposomal encapsulation of doxorubicin that is in Phase III clinical trial for treating primary liver cancer. The company is also developing GEN-1, a DNA-based immunotherapeutic product for the localized treatment of ovarian and brain cancers. Celsion Corporation was founded in 1982 and is headquartered in Lawrenceville, New Jersey.

Last 10 Buy Signals
Date Signal @
MLNUSDAug 8 - 00:0028.50
GNOUSDAug 7 - 23:59163.73
DGDUSDAug 7 - 23:59246.39
ZENUSDAug 7 - 23:5919.45
UBQUSDAug 7 - 23:590.0421
MLNUSDAug 7 - 23:5728.49
MAIDUSDAug 7 - 23:570.286
VTCUSDAug 7 - 23:570.151
RLCUSDAug 7 - 23:571.066
BTGUSDAug 7 - 23:5728.75

Stock Peers

Company Price Change
CLSN2.540.00%
BBI3.77-6.45%
BBLG1.455-10.74%
CYTH2.270.89%
ENSC0.433-8.82%
FBRX1.2204.27%
GMVD0.419-2.42%
IINN1.750-2.78%
NSPR1.9804.21%
PULM5.11-2.67%
TIVC2.63-6.07%

Latest Press Releases

Latest News

Disclaimer:

"JimStromberg.com" is a research service that provides financial data and technical analysis of publicly traded stocks. All users should speak with their financial advisor before buying or selling any securities. Users should not base their investment decision upon "JimStromberg.com". By using the site you agree and are held liable for your own investment decisions and agree to Terms of Use and Privacy Policy. Please read the full disclaimer here.